News & Updates

Reteplase a good alternative to alteplase in acute ischaemic stroke
Reteplase a good alternative to alteplase in acute ischaemic stroke
20 Feb 2024 byStephen Padilla

Treatment with reteplase appears more effective than alteplase in patients with acute ischaemic stroke (AIS) who have been treated within 4.5 hours of symptom onset, according to the results of RAISE, a phase III multicentre, open-label, randomized controlled, noninferiority trial.

Reteplase a good alternative to alteplase in acute ischaemic stroke
20 Feb 2024
Pharmacy model improves drug access, care transition in HF
Pharmacy model improves drug access, care transition in HF
20 Feb 2024
Earlier anticoagulation reversal tied to improved survival in ICH patients
Earlier anticoagulation reversal tied to improved survival in ICH patients
20 Feb 2024 byAudrey Abella

In anticoagulation-associated intracerebral haemorrhage (ICH), earlier administration of reversal treatments is associated with reduced in-hospital mortality or discharge to hospice, according to data presented at ISC 2024.

Earlier anticoagulation reversal tied to improved survival in ICH patients
20 Feb 2024